Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ANGIODYNAMICS INCANGO · Entity 5275 | Director | July 15, 2026 | July 23, 2026 |
| STEPAN COSCL · Entity 4733 | Director | May 08, 2026 | May 12, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ANGIODYNAMICS INC
Report date July 15, 2026 · Filed July 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 67,144 |
Reported balance
After 2026-07-15 transaction · row 1
1 source rowRow 1 · 2026-07-15 · Grant · Acquired 11,887 · Balance 67,144 F1: The acquisition of 11,887 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") represents 11,887 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: The acquisition of 11,887 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") represents 11,887 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of grant.
STEPAN CO
Report date May 08, 2026 · Filed May 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 5,900 |
Reported balance
After 2026-05-08 transaction · row 1
1 source rowRow 1 · 2026-05-08 · Grant · Acquired 2,566 · Balance 5,900 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 15, 2026 Filed Jul 23, 2026 00:06 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | GrantCommon Stock | 11,887 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-26-029337 · form4.xml · nonDerivative · entry 1 Burgess Lorinda · CIK 0001843912 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,144 F1 · shares: The acquisition of 11,887 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") represents 11,887 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of grant. Read SEC document |
| May 08, 2026 Filed May 12, 2026 23:23 UTC | STEPAN CO SCL · Entity 4733 | GrantCommon Stock | 2,566 | $52.61 | $134,997.26 |
DisclosureSEC source: 0000094049-26-000092 · form4.xml · nonDerivative · entry 1 Burgess Lorinda · CIK 0001843912 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,900 Read SEC document |
| July 16, 2025 Filed Jul 18, 2025 22:06 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | GrantCommon Stock | 17,675 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-25-026459 · form4.xml · nonDerivative · entry 1 Burgess Lorinda · CIK 0001843912 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,257 F1 · shares: The acquisition of 17,675 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") represents 17,675 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of grant. Read SEC document |
| May 12, 2025 Filed May 14, 2025 01:33 UTC | STEPAN CO SCL · Entity 4733 | GrantStock Awards · Derivative | 2,500 | $54.26 | $135,655.00 |
DisclosureSEC source: 0001127602-25-014169 · form4.xml · derivative · entry 1 Burgess Lorinda · CIK 0001843912 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,927 Underlying: Common Stock · 2,500 shares Expires not disclosed F1 · derivative.exercise_price: Each stock award represents the right to receive one share of issuer common stock. F2 · derivative.exercise_date: Deferred stock awards are payable in shares pursuant to the director's election either following separation from service or after a specified age. F2 · derivative.expiration_date: Deferred stock awards are payable in shares pursuant to the director's election either following separation from service or after a specified age. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 20:22 UTC | STEPAN CO SCL · Entity 4733 | GrantStock Awards · Derivative | 10 | $55.40 | $554.00 |
DisclosureSEC source: 0001127602-25-011396 · form4.xml · derivative · entry 1 Burgess Lorinda · CIK 0001843912 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,427 Underlying: Common Stock · 10 shares Expires not disclosed F1 · derivative.exercise_price: Each stock award represents the right to receive one share of issuer common stock. F2 · derivative.exercise_date: Deferred stock awards are payable in shares pursuant to the director's election either following separation from service or after a specified age. F2 · derivative.expiration_date: Deferred stock awards are payable in shares pursuant to the director's election either following separation from service or after a specified age. Read SEC document |
| July 17, 2024 Filed Jul 19, 2024 21:18 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | GrantCommon Stock | 20,541 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-033630 · form4.xml · nonDerivative · entry 1 Burgess Lorinda · CIK 0001843912 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,582 F1 · shares: The acquisition of 20,541 shares of common stock of AngioDynamics, Inc.("AngioDynamics") represents 20,541 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of grant. Read SEC document |
| May 10, 2024 Filed May 14, 2024 17:37 UTC | STEPAN CO SCL · Entity 4733 | GrantStock Awards · Derivative | 1,396 | $89.53 | $124,983.88 |
DisclosureSEC source: 0001127602-24-015210 · form4.xml · derivative · entry 1 Burgess Lorinda · CIK 0001843912 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,396 Underlying: Common Stock · 1,396 shares Expires not disclosed F1 · derivative.exercise_price: Each stock award represents the right to receive one share of issuer common stock. F2 · derivative.exercise_date: Deferred stock awards are payable in shares pursuant to the director's election either following separation from service or after a specified age. F2 · derivative.expiration_date: Deferred stock awards are payable in shares pursuant to the director's election either following separation from service or after a specified age. Read SEC document |
| July 19, 2023 Filed Jul 22, 2023 00:06 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | GrantCommon Stock | 17,041 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-035701 · form4.xml · nonDerivative · entry 1 Burgess Lorinda · CIK 0001843912 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,041 F1 · shares: The acquisition of 17,041 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") represents 17,041 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of grant. Read SEC document |
| April 25, 2023 Filed Apr 27, 2023 14:51 UTC | STEPAN CO SCL · Entity 4733 | GrantCommon Stock | 1,325 | $94.32 | $124,974.00 |
DisclosureSEC source: 0001127602-23-013618 · form4.xml · nonDerivative · entry 1 Burgess Lorinda · CIK 0001843912 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,334 Read SEC document |
| April 26, 2022 Filed Apr 28, 2022 10:41 UTC | STEPAN CO SCL · Entity 4733 | GrantCommon Stock | 1,249 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-012611 · form4.xml · nonDerivative · entry 1 Burgess Lorinda · CIK 0001843912 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,009 Read SEC document |
| April 27, 2021 Filed Apr 28, 2021 19:53 UTC | STEPAN CO SCL · Entity 4733 | GrantCommon Stock | 760 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-014565 · form4.xml · nonDerivative · entry 1 Burgess Lorinda · CIK 0001843912 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 760 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.